“…In young male mice, but not cycling young female mice, systemic low-dose AngII-infusion results in a slowly developing increase in blood pressure (Girouard et al 2009, Li et al 2008, Marques-Lopes et al 2015a, Marques-Lopes et al 2014, Marques-Lopes et al 2015b, Pinkerton & Stovall 2010, Tiwari et al 2009, Van Kempen et al 2015b, Xue et al 2013, Xue et al 2005). However, slow-pressor AngII-infusion induces hypertension in OVX mice that model surgical menopause (Hay et al 2014, Xue et al 2013) and in aged rodents (Fortepiani et al 2003, Marques-Lopes et al 2015b, Tiwari et al 2009) that model the acyclicity (Nelson et al 1995) seen in post-menopause. Using a mouse model of Accelerated Ovarian Failure (AOF) that uniquely recapitulates hormonal changes seen in human menopause (Van Kempen et al 2014, Van Kempen et al 2011), we showed that the susceptibility to slow-pressor AngII hypertension begins at emerges at a timepoint that mimics perimenopause (i.e., when estrogens are present but erratically fluctuating) [9].…”